Estimaciones de analistas de Wall Street para MediWound Ltd. (MDWD): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-19 | $-0.71 | ||
| 2026-08-13 | $-0.77 | $-0.76 | -1.1% |
| 2026-05-27 | $-0.23 | $-0.65 | +64.6% |
| 2026-03-05 | $-0.56 | $-0.65 | +13.8% |
| 2025-11-20 | $-0.24 | $-0.81 | +70.4% |
| 2025-08-14 | $-1.23 | $-0.55 | -123.6% |
| 2025-05-21 | $-0.07 | $-0.65 | +89.2% |
| 2025-03-19 | $-0.36 | $-0.59 | +39.0% |
Ratios de valoración
| Precio / Valor contable | 4.78 |
| EV / EBITDA | -9.20 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.6M | $2.5M | $3.4M | $31.8M | $21.8M | $23.8M | $26.5M | $18.7M | $20.2M | $17.0M |
| Coste de Ventas | $2.2M | $1.6M | $2.1M | $11.8M | $14.2M | $15.0M | $13.3M | $15.1M | $17.6M | $13.7M |
| Beneficio Bruto | -$600000 | $918000 | $1.3M | $19.9M | $7.5M | $8.8M | $13.2M | $3.6M | $2.6M | $3.3M |
| I+D | $7.1M | $5.5M | $4.1M | $5.0M | $7.7M | $10.3M | $10.2M | $7.5M | $8.9M | $14.3M |
| Generales y Administrativos | $12.4M | $9.1M | $7.9M | $9.1M | $8.5M | $9.5M | $10.4M | $11.4M | $12.9M | $13.9M |
| Gastos Operativos | $19.6M | $14.6M | $5.3M | $15.4M | $16.4M | $20.0M | $20.8M | $19.1M | $22.0M | $28.5M |
| Beneficio Operativo | -$20.2M | -$13.7M | -$4.0M | $4.5M | -$8.8M | -$11.2M | -$7.7M | -$15.5M | -$19.4M | -$25.3M |
| EBITDA | -$17.4M | -$13.1M | -$4.2M | $4.1M | -$7.4M | -$11.4M | -$18.2M | -$4.8M | -$27.9M | -$21.5M |
| Gastos por Intereses | 0 | 0 | 0 | $207000 | $200000 | $167000 | $162000 | $335000 | $561000 | $662999 |
| Beneficio Antes de Impuestos | -$18.9M | -$14.5M | -$5.7M | $2.1M | -$9.3M | -$13.5M | -$19.5M | -$6.5M | -$30.2M | -$23.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $27000 | $78000 | $185000 | $61000 | $169000 |
| Beneficio Neto | -$18.9M | -$22.1M | -$1.1M | $5.0M | -$9.2M | -$13.6M | -$19.6M | -$6.7M | -$30.2M | -$23.9M |
| BPA | $-6.05 | $-6.64 | $-0.28 | $1.26 | $-2.38 | $-3.48 | $-3.93 | $-0.75 | $-3.03 | $-2.10 |
| BPA Diluido | $-6.05 | $-6.64 | $-0.28 | $1.26 | $-2.38 | $-3.48 | $-3.93 | $-0.75 | $-3.03 | $-2.10 |
| Acciones en Circulación (Diluidas) | $3.1M | $3.3M | $3.9M | $3.9M | $3.9M | $3.9M | $5.0M | $9.0M | $10.0M | $11.4M |
Precio
| Precio | $13.22 |
| Capitalización | $170M |
| Bolsa | NASDAQ |
| País | IL |
Empresas relacionadas: AARD · EPRX · GNFT · IVA · IVVD · NTHI · OBIO
Explorar sector: Healthcare · Biotechnology
Más secciones de MDWD: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones